Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveResults30 Jul 2026

Mankind Pharma Ltd

Please find attached investor presentation for Q1FY27

Mankind Pharma Ltd has announced its Q1FY27 investor presentation, showcasing a 12.9% YoY growth in revenue from operations, with domestic business (ex-CH) growing 10.5% YoY and exports business growing 29% YoY. The company has also reported a 16.5% YoY growth in gross profit and a 24.7% YoY growth in EBITDA. The presentation highlights the company's steady growth trajectory, expansion in specialty and super specialty segments, and strong performance in key focused brands.

Read more →📎 1 attachment
BSEBoard MeetingResults30 Jul 2026

Vapi Enterprise Ltd

1. Un-audited Financial Statement: 2. Limited Review Report 3. Resignation of Independent Director: 4. Appointment of Independent Director: 5. Composition of Various Committees: 6. ....

Vapi Enterprise Ltd has announced its un-audited financial results for the quarter ended 30th June, 2026, and has approved the resignation of Independent Director Mr. Himanshu Ruia and the appointment of Mr. Sanket Goyal as an Additional Non-Executive Independent Director. The company has also reconstituted its Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee. Additionally, the Board has approved the re-appointment of Mr. Manoj Patel as the Managing Director for a period of five years.

Read more →📎 1 attachment
BSECompany UpdateResults30 Jul 2026

Global Health Ltd

Announcement regarding appointment of Mr. Pradeep Kumar Singh as one of the Senior Management Personnel.

Global Health Ltd has announced the appointment of Mr. Pradeep Kumar Singh as Chief Digital Officer and one of the Senior Management Personnel. The company has also approved the unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The board has fixed the record date for the payment of final dividend for the financial year 2025-26, which will be paid to the shareholders within 30 days from the date of declaration. The company has also increased the proposed bed capacity of its upcoming hospital at Guwahati from 400 beds to 650 beds.

Read more →📎 1 attachment
BSEInsider Trading / SASTRegulatory30 Jul 2026

Leela Palaces Hotels & Resorts Ltd

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 30, 2026 for Project Ballet ....

Leela Palaces Hotels & Resorts Ltd has received revised disclosure under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 for Project Ballet, regarding the creation of encumbrance on equity shares of the company.

Read more →📎 1 attachment
BSEBoard MeetingFundraise30 Jul 2026

Kanel Industries Ltd

Outcome of Board Meeting of Kanel Industries Limited

Kanel Industries Ltd has announced the outcome of its board meeting, where it approved a fund raising of up to Rs. 17 Crore through a rights issue to eligible equity shareholders. The company also appointed Ms. Pooja Khakhi as an Additional Director and noted the resignation of Ms. Jasmin Doshi as Non Executive Independent Director.

Read more →📎 1 attachment
BSECompany Update30 Jul 2026

Fluidomat Ltd

Submission of press clipping published on 30.07.2026 for "Special window for transfer and dematerialization of physical shares"

Fluidomat Ltd has announced a special window for transfer and dematerialization of physical shares that were sold or purchased prior to April 1, 2019, and transfer requests that were lodged prior to the deadline of April 1, 2019, but were rejected or returned due to deficiency in documents or otherwise. Eligible shareholders can submit their transfer requests along with physical share certificates until February 4, 2027.

Read more →📎 1 attachment
BSECompany UpdateResults30 Jul 2026

Mankind Pharma Ltd

Board of Directors of the Company in its meeting held today has inter-alia considered and approved the issuance of corproate guarantee in favour of Bharat Serums & Vaccines Limited, a WOS.

Mankind Pharma Ltd's board of directors has approved the issuance of a corporate guarantee in favor of Bharat Serums & Vaccines Limited, a wholly-owned subsidiary, and has also considered and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Read more →📎 1 attachment
← PreviousPage 2514 of 3070Next →